This online, on-demand virtual symposium brings together renowned experts in breast cancer. In this educational program, these experts provide guidance on integrating and sequencing HER2- and TROP2-directed antibody-drug conjugate (ADC) therapies to optimize patient selection and improve outcomes across early and advanced breast cancer settings. This educational activity is an archive of the live symposium held on March 6, 2026.
Credit & MOC Details
Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.
Credit types
MOC types
FDA REMS
Qualifies for MIPS
Target Specialties
Pricing
100% of listed courses are free
272 of 272 courses listed here are free.
Collected from the provider’s public pages · source
Specialties served/covered
- Allergy & Clinical Immunology
- Anatomic & Clinical Pathology
- Cardiovascular Disease
- Communication & Shared Decision-Making
- Dermatology
- Endocrinology, Diabetes & Metabolism
- Evidence-Based Medicine & Research
- Family Medicine
- Gastroenterology
- Gastrointestinal Surgery
- General & Adult Psychiatry
- General Internal Medicine
- General Pediatrics
- Geriatric Medicine
- Gynecologic Oncology
- Head & Neck Surgery
- Health Equity & Inclusion
- Hematology
- Infectious Disease
- Medical Oncology
- Metabolic & Bariatric Surgery
- Mood & Anxiety Disorders
- Nephrology
- Neurology
- Neuromuscular Medicine
- Neuroradiology
- Neurosurgery
- Nuclear Medicine
- Ophthalmology
- Pediatric Hematology-Oncology
- Psychotic Disorders
- Pulmonary Disease
- Radiation Oncology
- Rheumatology
- Surgical Oncology
- Urological Oncology
- Cardio-Vascular
- Cross-Specialty
- ENT & Head Neck
- GI & Liver
- Infectious Disease
- Internal Medicine
- Medical Subspecialties
- Neurology
- Oncology & Hematology
- Pathology & Lab
- Pediatrics
- Primary care
- Psychiatry
- Radiology
- Surgery
- Urology
- No reviews yet. Be the first to share yours.
- On-demand / recorded video
- Credit · Up to 1.5 credits
- Commercial Support
-
ReleasedMar 30, 2026
-
Last day to claim creditMar 31, 2027 6 months left
-
PRIME Education, Inc. (PRIME®) Integrating Trop-2 Directed ADCs Into HR+/HER2- Breast Cancer Care
-
EfficientCME, CME Outfitters, LLC From Data to Decisions: An Integrated CME Activity Designed to Assess and Compare the Practice Patterns of Specialists and General Oncologists Related to the Management of HER2-Negative Metastatic Breast Cancer
-
Clinical Care Options, LLC (dba Decera Clinical Education) Integrating HER2-Directed ADCs Across Early and Metastatic Breast Cancer: Practical Strategies for Testing, Sequencing, and Patient-Centered Care
-
Physicians’ Education Resource The ADC Revolution in Metastatic Breast Cancer: Redefining Treatment Selection and Sequencing
-
Physicians’ Education Resource Show Me Your Care Plan!(TM) Navigating ADC Therapies: Oncology Nursing Strategies for Optimal Patient Management
-
Physicians’ Education Resource Cases and Conversations-Evolving Radiation Strategies in HER2-Positive Breast Cancer: Early-Stage Through Metastatic Disease
